Embase content is updated daily and expanding globally
Embase provides unparalleled coverage of the medical literature, including information not available in MEDLINE. Regulatory bodies recommend Embase as a source for comprehensive systematic literature reviews.
By the numbers: current Embase coverage
Embase journal coverage is from 1947 on with historical records included in Embase Classic.
45.6 million records, an average of 8,535 new entries daily and over 12 million records not in MEDLINE
3,365 journals unique to Embase and 8,451 currently published journals, including MEDLINE titles
5.1 million conference abstracts from 15,577 conferences
99,730 preferred terms in Emtree with 525,755 synonyms, 64 drug subheadings, 14 disease subheadings, 4 device subheadings
95 countries represented in journal selection. Local literature modules available as add-on
Download a list of journals opens in new tab/window currently covered in Embase.
Download a list of the conferences opens in new tab/window currently covered in Embase.
Ready to take the next step?
FAQs
More than 8,000 new records are added to Embase every working day. That's over 2.9 million new records each year. Articles in press and in process are added to Embase as soon as they are available. Over 400,000 of the records added to Embase each year are conference abstracts.
We have recently reviewed our process for receiving journal submissions.
After carefully reading the process described below and verifying that your journal fulfills all our criteria, you can submit the title via the new suggestion form.
The selection decision takes 12 months. Once approved, a journal is added to Embase from January of the following year when selected in H2, or September of the year of selection if selected in H1.
Every year, over 1000 new titles are suggested for inclusion in Embase, but fewer than 50% of those titles meet the technical criteria and, after careful prioritization based on our key scope topics, only 10% are finally selected.
To ensure that Embase serves the broad information needs of researchers, we continuously review suggestions and publishing programs in order to expand our content listings. We review new titles using both quantitative and qualitative measures. Suggestions may be made by publishers or editors of a title. Individual researchers and librarians can also suggest titles for Embase, but these suggestions need to be supported by the publisher and/or editor. Before suggesting a serial title, please:
Check the current Embase title list on the top of this page to be sure it's not already indexed.
Review the selection criteria on this page in the section “How are journals evaluated for coverage in Embase?”.
Then use the Embase selection form opens in new tab/window.
Ready to suggest a title? Complete this form opens in new tab/window.
To be considered for review, all journal titles should meet all these minimum criteria:
Scientific quality and editorial coverage
Peer-reviewed content with a publicly available description of the peer review process
English language abstracts and titles
Diversity in geographical distribution of editors and authors
Clarity of abstracts, quality of and conformity to the stated aims and scope of the journal, readability of articles
Information about the journal
Published periodically and availability of ISSN
Available in electronic format
Publicly available publication ethics and publication malpractice statement
Clear and convincing editorial policy
Website accessible in English
Scope, subject and geographic coverage
The content of the recommended journal must be in the scope and subject areas covered by Embase for consideration. The submission form includes an Embase classification list from which covered subjects can be selected.
Title re-evaluation
The quality of our content is paramount for Elsevier. In addition to journals undergoing a rigorous evaluation and selection processes prior to acceptance into Elsevier, they must also demonstrate the ability to maintain their quality status year over year.
To determine journal quality, Elsevier runs the ongoing re-evaluation program that identifies outlier and underperforming journals.
Local literature modules in Embase
Embase has a French Local Literature Module. It enables users to monitor French-language journals for adverse drug reactions and helps you comply with EMA requirements.
More than 100 relevant journals identified based on input from industrial partners, the EMA and ANSM
Full-text articles translated using human-aided machine translation with human quality control
Translated full-text articles are manually indexed using Emtree
Embase data for applied analytics
Embase content is available as enriched, machine-readable data. It can be licensed off platform to:
Enrich content via semantic tagging for machine readability
Organize and connect content to reveal concepts and relationships
Enhance KOL databases for internal use
Combine Embase data with other data sources for: - Competitive intelligence dashboards - Regulatory and medical affairs insights - Market access analysis and positioning
We offer flexible data packages, supported by a team of data experts, to help your projects succeed. Combine and text mine internal and external datasets to aid insight and discovery across medical affairs, regulatory, and drug discovery. Embase data includes drug and device names, synonyms and relevant terms:
Generic drug names from the FDA/EMA
International nonproprietary names (INNs) for drugs
Drug trade names
Diseases, organisms, biological functions, medical and biological parameters
Global medical device nomenclature (GMDN) used by the FDA
Contact us to discuss how Embase data can enhance your scientific intelligence, risk monitoring, and development and payer strategy.